2020
Search results
Jennifer Anne Doudna (Washington D. C., 19 de febrero de 1964 [1] ) es una bioquímica estadounidense, catedrática de Química y Biología celular y molecular en la Universidad de California, Berkeley. [2]
8 de oct. de 2020 · En la actualidad, Jennifer Doudna fomenta el uso ético de las tecnologías de edición genética. Fotografía de Erika Larsen. Nota del editor: Jennifer Doudna y Emmanuelle Charpentier han sido galardonadas con el Premio Nobel de Química de 2020 por el desarrollo de un método para la edición del genoma.
Reconocida por descifrar los mecanismos moleculares del sistema inmunológico bacteriano CRISPR-Cas9. Premios: Premio Nobel de Química 2020... Campos: Bioquímica, genética, microbiólogía. Padres: Hija de Dorothy Jane (Williams) y Martin Kirk Doudna. Cónyuges: Tom Griffin, Jamie Cate.
Jennifer Anne Doudna ForMemRS (/ ˈ d aʊ d n ə /; born February 19, 1964) is an American biochemist who has done pioneering work in CRISPR gene editing, and made other fundamental contributions in biochemistry and genetics. Doudna was one of the first women to share a Nobel in the sciences.
Biochemist Jennifer Doudna is best known for her pioneering work in CRISPR gene editing, for which she was awarded the 2020 Nobel Prize in chemistry. She's also a leading biotech entrepreneur, with several life science start-ups under her belt.
The Nobel Prize in Chemistry 2020 was awarded jointly to Emmanuelle Charpentier and Jennifer A. Doudna "for the development of a method for genome editing"
Jennifer A. Doudna The Nobel Prize in Chemistry 2020. Born: 19 February 1964, Washington, D.C., USA. Affiliation at the time of the award: University of California, Berkeley, CA, USA. Prize motivation: “for the development of a method for genome editing” Prize share: 1/2. Work.
